A new sociomedical perspective shows how off-label use of GLP-1 drugs for slimness is redefining what counts as a healthy, responsible body, revealing hidden moral pressures and global inequalities behind the weight loss boom
It fluctuates with our bodies circadian (day-night) rhythm and helps guide normal sleep-wake cycles
Beyond its approved indication, PT-141 has been investigated and used off-label for male erectile dysfunction, particularly in men who don't respond to PDE5 inhibitors or have contraindications to their use
[DOI] [PMC free article] [PubMed] [Google Scholar] [219].Patel V, Joharapurkar A, Dhanesha N, Kshirsagar S, Patel K, Bahekar R, Shah G, Jain M, Co-agonist of glucagon and GLP-1 reduces cholesterol and improves insulin sensitivity independent of its effect on appetite and body weight in diet-induced obese C57 mice, Can J Physiol Pharmacol, 91 (2013) 10091015